key: cord-0935788-ioon0srg authors: Alcoba-Florez, J.; Gil-Campesino, H.; Garcia-Martinez de Artola, D.; Gonzalez-Montelongo, R.; Valenzuela-Fernandez, A.; Ciuffreda, L.; Flores, C. title: Sensitivity of different RT-qPCR solutions for SARS-CoV-2 detection date: 2020-06-24 journal: nan DOI: 10.1101/2020.06.23.20137455 sha: 770f1485059c4e808d7a14293ad3f918080dfd7a doc_id: 935788 cord_uid: ioon0srg Objectives: The ongoing COVID-19 pandemic continues imposing a demand for diagnostic screening. In anticipation that the recurrence of outbreaks and the measures for lifting the lockdown worldwide may cause supply chain issues over the coming months, we assessed the sensitivity of a number of one-step retrotranscription and quantitative PCR (RT-qPCR) solutions to detect SARS-CoV-2. Methods: We evaluated six different RT-qPCR alternatives for SARS-CoV-2/COVID-19 diagnosis based on standard RNA extractions. That of best sensitivity was also assessed with direct nasopharyngeal swab viral transmission medium (VTM) heating, overcoming the RNA extraction step. Results: We found a wide variability in the sensitivity of RT-qPCR solutions that associated with a range of false negatives from as low as 2% (0.3-7.9%) to as much as 39.8% (30.2-50.2). Direct preheating of VTM combined with the best solution provided a sensitivity of 72.5% (62.5-81.0), in the range of some of the solutions based on standard RNA extractions. Conclusions: We evidenced sensitivity limitations of currently used RT-qPCR solutions. Our results will help to calibrate the impact of false negative diagnoses of COVID-19, and to detect and control new SARS-CoV-2 outbreaks and community transmissions. The ongoing pandemic of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causing the coronavirus disease 2019 has imposed an increasing demand for daily diagnostic screening. This is expected to perpetuate over the coming months due to the recurrence of outbreaks and the lifting of lockdown measures worldwide (Patel et al. 2020) . Given the high sensitivity compared to serological testing (Cassaniti et al. 2020) , standard diagnosis continues to rely on RNA extractions from respiratory or oral samples followed by one-step reverse transcription and real-time quantitative PCR (RT-qPCR) that entail one or several primer-probe sets for targeting SARS-CoV-2 sequences (Corman et al. 2020) . While it has been shown that protocol modifications aiming to overcome supply chain issues and accelerate diagnosis affect assay sensitivity (Alcoba-Florez et al. 2020; Esbin et al. 2020) , differences in target priming efficiencies and RT-qPCR kit components are also expected to account for dissimilarities in false negative results (Nalla et al. 2020 ). Here we aimed to evaluate the sensitivity of six different RT-qPCR solutions, including five marketed kits and one based on the World Health Organization diagnostic assays with the best sensitivity (Corman et al. 2020; Vogels et al. 2020) , using RNA extractions from nasopharyngeal swab viral transmission medium (VTM). The alternative with the best sensitivity was also assessed by a direct preheating of VTM samples to skip the RNA extraction step that was described elsewhere (Alcoba-Florez et al. 2020) . The study was conducted at the University Hospital Nuestra Señora de Candelaria (Santa Cruz de Tenerife, Spain) from March to June 2020. We evaluated six different . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 24, 2020. . https://doi.org/10.1101/2020.06.23.20137455 doi: medRxiv preprint RT-qPCR solutions (Table 1) Since all samples were COVID-19 positive for at least one solution/viral target, results with threshold cycle (Ct) values above 40 or those that remained undetected during the 45 cycles of the experiments were considered FN observations (Figure 1, Table 1 ). Attending to individual targets, we found that the most sensitive solution was the LightMix® Modular SARS-CoV (COVID19) (TIB MOLBIOL) used in combination with a primer-probe set for the E-gene (97. 9% [92.8-99 .7]) ( Table 1) . It was followed closely by the TaqMan Fast Virus 1-Step Master Mix (Thermo Fisher Scientific) kit combined with validated primer-probes for diagnosis (Corman et al. 2020) for the same viral gene (95.9% [89.9-98.9]). When combining at least two viral gene targets, we . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 24, 2020. Table 1 ). RT-qPCR for selected target genes of SARS-CoV-2 has been key in the global response to the pandemic. Given the rapid spread of the virus at this time, it is likely that the RT-qPCR assays will continue to be a central tool for controlling COVID-19. However, as happened in the past due to supply chain issues, policy decisions and laboratory testing capacities (Alcoba-Florez et al. 2020) , it is predictable that the diagnosis of COVID-19 will continue relying on a variety of solutions among laboratories and countries (Vogels et al. 2020) . Our results evidenced a wide variability in the sensitivity of RT-qPCR solutions for SARS-CoV-2 detection which associated with a proportion of FN ranging from as low as 2% (0.3-7.9%) to as much as 39.8% (30.2-50.2). These findings will help to assess the impact of the selected solution on FN diagnoses of COVID-19 (Ramdas et al. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 24, 2020. . https://doi.org/10.1101/2020.06.23.20137455 doi: medRxiv preprint 6 2020) and to choose a solution that minimize misdiagnoses of an active SARS-CoV-2 infection. JAF and CF designed the study. JAF, HGC, and DGM participated in data acquisition. JAF, LC and CF performed the analyses and data interpretation. LC, AVF, RGM and CF wrote the draft of the manuscript. All authors contributed in the critical revision and final approval of the manuscript. We deeply acknowledge the University Hospital Nuestra Señora de Candelaria board of directors and the executive team for their strong support and assistance in accessing diverse resources used in the study. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 24, 2020. . https://doi.org/10.1101/2020.06.23.20137455 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 24, 2020. Corman et al. (2020) . Fast SARS-CoV-2 detection by RT-qPCR in preheated nasopharyngeal swab samples Members of the San Matteo Pavia COVID-19 Task Force. Performance of VivaDiag COVID-19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID-19 in acute patients referring to emergency room department Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR Overcoming the bottleneck to widespread testing: A rapid review of nucleic acid testing approaches for COVID-19 detection Comparative Performance of SARS-CoV-2 Detection Assays Using Seven Different Primer-Probe Sets and One Assay Kit Report from the American Society for Microbiology COVID-19 International Summit Test, re-test, re-test': using inaccurate tests to greatly increase the accuracy of COVID-19 testing Analytical sensitivity and efficiency comparisons of SARS-COV-2 qRT-PCR primer-probe sets International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 24, 2020. . https://doi.org/10. 1101